Search

everythinglearnresearchcommunity

for

Search:↓

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Clobetasol propionate 0.05% is more effective for hair re-growth in alopecia areata than tacrolimus 0.1%.

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

One minoxidil-sensitive potassium channel exists in human hair follicles.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

A new topical treatment using micelles shows promise for safer and more effective hair regrowth in androgenetic alopecia.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

β-estradiol slows hair growth in mice.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Testosterone may worsen hair loss by affecting hair growth signals, while different prostaglandins can either hinder or promote hair growth.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Bicalutamide may reduce unwanted hair growth caused by minoxidil in women with hair loss.

A man had an allergic reaction to minoxidil, which stopped after he discontinued use and started corticosteroids.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.

Topical prostaglandin E2 can help treat both alopecia areata and vitiligo.

POMC-derived peptides are important for skin functions like immune response and stress management.

Prolactin and TGF-β receptor blockers might help treat hair loss.

Melatonin stops melanin production after tyrosinase action, with cyclic GMP mimicking this effect.

Finasteride effectively prevents hair loss and promotes hair growth in men with androgenetic alopecia.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Finasteride reduces melanin production in skin cells.

The emulgel formulation F6 released more Minoxidil than the gel formulation F1.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.